Launch Day Is Too Late: Why Pharma Needs AI Monitoring Before the Press Release Drops
When Novo Nordisk’s semaglutide brand Ozempic became a cultural phenomenon in 2022, the company’s brand team faced a problem they […]
When Novo Nordisk’s semaglutide brand Ozempic became a cultural phenomenon in 2022, the company’s brand team faced a problem they […]
A physician asks ChatGPT about the maximum daily dose of apixaban before a procedure. The model responds with a figure
A patient types ‘Can I take Ozempic if I have pancreatitis?’ into ChatGPT. The model responds with an answer. That
A patient asks ChatGPT how much metformin to take. The answer comes back confident, formatted like a clinical protocol, and
A patient types ‘Can I take Ozempic and metformin together?’ into ChatGPT. A physician asks Gemini about semaglutide dosing for
When a patient types ‘what’s the best GLP-1 for weight loss’ into ChatGPT, the answer they get back is not
The FDA didn’t send a warning letter. No patient filed an adverse event report. No journalist called. But somewhere between
A patient asks ChatGPT how much metformin to take. The answer comes back confident, formatted like a clinical protocol, and
When a patient types ‘Ozempic vs. Wegovy: which is better for weight loss?’ into ChatGPT, they get an answer in
Somewhere right now, a patient is asking Perplexity whether their new prescription interacts with ibuprofen. Another is asking ChatGPT how
When a patient types “is Ozempic safe for people with a history of pancreatitis?” into ChatGPT, the answer they receive
Every month, tens of millions of patients and physicians type drug safety questions into ChatGPT, Gemini, Perplexity, and Claude. The
Sign in or create a free account to read this DrugChatter article